Disclaimer: this software uses AI to aggregate and filter content. Please double-check sources before putting info to action.
📰 News Media
- ⚖️ Human Rights and Harm Reduction 2.0: Beyond HIV and the Evidentiary Double Standard in Drug Policy - hhrjournal.org
- 🧪 [National] NIST Study Shows How the Toxic Substances Mixed Into Fentanyl Vary Across the U.S. and Change Over Time - nist.gov
- ⚠️ [Austin, TX] Austin police warn about dangerous, unregulated opioid products sold at smoke shops - yahoo.com
- ⚖️ [Pennsylvania] High court rejects challenge to how Pa. treats users accused of supplying drugs in fatal overdoses - ca.news.yahoo.com
🗣️ Social Pulse
Lived/Living Experience
Innovation
- 📱 For adults initiating #Buprenorphine during hospitalization, a patient navigation and #mHealth incentive intervention was feasible to deliver and highly rated, with similar outpatient linkage as usual care in this... - @JAMANetworkOpen on X
- 🧪 The Transparency Triple Check: 1️⃣ Screen with strips (fentanyl, xylazine, nitazene) 2️⃣ Use multiple reagents to see if your sample reacts as expected 3️⃣ Compare with lab-verified videos in the Transparency Harm... - @BunkPolice on X
Opposition Views
🏙 City Updates
- No recent City Updates found.
📚 Academic Research
- 🚑 Responding to the Fentanyl Overdose Crisis With a Tri-Government Incident Command Structure in Portland, Oregon, 2024. - PubMed - 2026-10-13 - doi.org
- 🌍 Substance use, related harms and public health responses in Colombia: A national profile - Addiction - 2026-10-13 - doi.org
- 📱 Patient Navigation Plus mHealth Incentives for Linkage to OUD Care for Adults Who Also Use Methamphetamines - JAMA Network Open - 2026-10-13 - doi.org
⚖️ Law & Policy
City Ordinances
💸 Funding
Current
- Deadline Approaching🛠️ Bureau of Justice Assistance - BJA FY 2026 Comprehensive Opioid, Stimulant, and Substance Use Program (COSSUP) Training and Technical Assistance (TTA) - Deadline: Nov 2, 2026
- 🧒 Office of Juvenile Justice Delinquency Prevention - OJJDP FY 2026 Mentoring for Youth Impacted by Opioids and Other Substance Use - Deadline: Nov 16, 2026
- 🧒 Office of Juvenile Justice Delinquency Prevention - OJJDP FY 2026 Opioid Affected Youth Initiative - Deadline: Nov 16, 2026
- 🔬 National Institutes of Health - HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR) - Building Engagement, Assistance, Capacity, Outreach, and Networks (BEACON) Center (U2C Clinical Trial Not Allowed) - Deadline: Jan 26, 2027
- 🔬 National Institutes of Health - HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required) - Deadline: Jan 26, 2027
- 🔬 National Institutes of Health - Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) - Deadline: Jun 16, 2028
- 🔬 National Institutes of Health - Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional) - Deadline: Aug 21, 2028
- 🔬 National Institutes of Health - Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional) - Deadline: Sep 25, 2028
- 🔬 National Institutes of Health - HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional) - Deadline: Feb 9, 2029
- 🏥 Hearst Foundations - Health - Hearst Foundations Health Grants - Minimum grant size is $100,000; consult the Grant Recipients Database for amounts awarded to comparable organizations. - Deadline: Year-round rolling application; no deadlines.
- 🤝 Hearst Foundations - Social Service - Hearst Foundations Social Service Grants - Minimum grant size is $100,000; consult the Grant Recipients Database for amounts awarded to comparable organizations. - Deadline: Year-round rolling application; there are no deadlines.